formoterol
Selected indexed studies
- Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. (N Engl J Med, 2018) [PMID:29768149]
- The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. (J Allergy Clin Immunol Pract, 2023) [PMID:36639054]
- Glycopyrronium/Formoterol: A Review in COPD. (Drugs, 2019) [PMID:31468315]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. (2018) pubmed
- Inhaled budesonide/formoterol combination. (2001) pubmed
- The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. (2023) pubmed
- Glycopyrronium/Formoterol: A Review in COPD. (2019) pubmed
- Budesonide/Glycopyrronium/Formoterol: A Review in COPD. (2021) pubmed
- Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease. (2020) pubmed
- Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial. (2025) pubmed
- Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update. (2021) pubmed
- Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma. (2023) pubmed
- Glycopyrrolate and formoterol fumarate for the treatment of COPD. (2021) pubmed